Kun Peng

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 466 citations

Medicine, Internal Medicine, Pharmacology +10

A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

Jasvinder K. Atwal, Yongmei Chen, Cecilia Chiu et al. · Science Translational Medicine · 2011 · 277 citations

Life Sciences, Neurobiology, Neuroscience +15

Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations

Dawn L. Harmon, Denis C. Shields, Jayne V. Woodside et al. · Genetic Epidemiology · 1999 · 257 citations

Life Sciences, Genetics, Molecular Genetics +14

Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies

Hongjian Li, Kun Peng, Kai Yang et al. · Theranostics · 2022 · 229 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials

Margaret Neighbors, Christopher R. Cabanski, Thirumalai R. Ramalingam et al. · The Lancet Respiratory Medicine · 2018 · 117 citations

Medicine, Internal Medicine, Pharmacotherapy +10